UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparisons of global coagulation potential and bleeding episodes in emicizumab-treated hemophilia A patients and mild hemophilia A patients

International journal of hematology, 2022-04, Vol.115 (4), p.489-498

2022

Volltextzugriff (PDF)

Global coagulation function assessed by rotational thromboelastometry predicts coagulation-steady state in individual hemophilia A patients receiving emicizumab prophylaxis

International journal of hematology, 2019-10, Vol.110 (4), p.419-430

2019

Volltextzugriff (PDF)

Blood coagulation dynamics during adrenocorticotropic hormone therapy in pediatric patients with infantile spasms

Brain & development (Tokyo. 1979), 2022-09, Vol.44 (8), p.546-550

2022

Volltextzugriff (PDF)

A novel simultaneous clot‐fibrinolysis waveform analysis for assessing fibrin formation and clot lysis in haemorrhagic disorders

British journal of haematology, 2019-11, Vol.187 (4), p.518-529

2019

Volltextzugriff (PDF)

Hemostatic rebalance in neonatal intrahepatic cholestasis with citrin deficiency

Pediatrics international, 2022-01, Vol.64 (1), p.e14741-n/a

2022

Volltextzugriff (PDF)

Hemostatic potential of recombinant von Willebrand factor and standard or pegylated extended half-life recombinant factor VIII on thrombus formation under high shear flow

Thrombosis journal, 2023-12, Vol.21 (1), p.122-122, Article 122

2023

Volltextzugriff (PDF)

A modified thrombin generation assay to evaluate the plasma coagulation potential in the presence of emicizumab, the bispecific antibody to factors IXa/X

International journal of hematology, 2020-11, Vol.112 (5), p.621-630

2020

Volltextzugriff (PDF)

Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients

Blood, 2019-09, Vol.134 (11), p.880-891

2019

Volltextzugriff (PDF)

Two pediatric cases of severe hemophilia A in which emicizumab prophylaxis failed to prevent traumatic extra-articular hemorrhage

International journal of hematology, 2023-04, Vol.117 (4), p.607-612

2023

Volltextzugriff (PDF)

A Novel Assessment of Factor VIII Activity by Template Matching Utilizing Weighted Average Parameters from Comprehensive Clot Waveform Analysis

Thrombosis and haemostasis, 2021-02, Vol.121 (2), p.164-173

2021

Volltextzugriff (PDF)

Potential role of activated factor VIII (FVIIIa) in FVIIa/tissue factor-dependent FXa generation in initiation phase of blood coagulation

International journal of hematology, 2019-04, Vol.109 (4), p.390-401

2019

Volltextzugriff (PDF)

High levels of factor VIII activity in patients with acquired hemophilia A in remission are associated with unusually low coagulation potentials

International journal of hematology, 2023-05, Vol.117 (5), p.669-677

2023

Volltextzugriff (PDF)

Modified expi293 cell culture system using piggyBac transposon enables efficient production of human FVIII

International journal of hematology, 2023, Vol.117 (1), p.56-67

2023

Volltextzugriff (PDF)

Characterization of thrombophilia-related plasmas evaluated by anticoagulants-mediated thrombin and plasmin generation assays

Blood coagulation & fibrinolysis, 2022-09, Vol.33 (6), p.327-336

2022

Volltextzugriff (PDF)

Activated partial thromboplastin time-based clot waveform analysis enables measurement of very low levels of factor IX activity in patients with severe hemophilia B

International journal of hematology, 2022-11, Vol.116 (5), p.778-786

2022

Volltextzugriff (PDF)

A mild hemophilia B case with postoperative bleeds following thromboprophylaxis

Pediatric investigation, 2022-01, Vol.64 (1), p.e15365-n/a

2022

Volltextzugriff (PDF)

A case of a young boy with hyper-fibrinolysis associated with natural fibrin precipitates suspected to have occurred through a novel coagulation and fibrinolysis mechanism

International journal of hematology, 2022-08, Vol.116 (2), p.276-287

2022

Volltextzugriff (PDF)

A microchip flow‐chamber assay screens congenital primary hemostasis disorders

Pediatrics international, 2021-02, Vol.63 (2), p.160-167

2021

Volltextzugriff (PDF)

Assessment of Emicizumab-Driven Clot Stability in Hemophilia a Model

Blood, 2018-11, Vol.132 (Supplement 1), p.2478-2478

2018

Volltextzugriff (PDF)

The spleen is the major site for the development and expansion of inhibitor producing-cells in hemophilia A mice upon FVIII infusion developing high-titer inhibitor

Thrombosis research, 2023-11, Vol.231, p.144-151

2023

Volltextzugriff (PDF)

Evaluation of clinical severity in patients with type 2N von Willebrand disease using microchip-based flow-chamber system

International journal of hematology, 2020-03, Vol.111 (3), p.369-377

2020

Volltextzugriff (PDF)

Screening of the protein C pathway abnormality‐related thrombophilia by using thrombomodulin‐mediated tissue factor‐triggered clot waveform analysis

European journal of haematology, 2022-07, Vol.109 (1), p.100-108

2022

Volltextzugriff (PDF)

Hemostatic function in hyperfibrinolytic disseminated intravascular coagulation

Pediatrics international, 2019-09, Vol.61 (9), p.872-881

2019

Volltextzugriff (PDF)

Mechanism of Tissue Factor (TF) Enhancing Factor (F)VIII Activity on FXa Generation in Initial Phase of Coagulation and Interaction Between TF and FVIII C2 Domain

Blood, 2016-12, Vol.128 (22), p.1391-1391

2016

Volltextzugriff (PDF)

Comprehensive blood coagulation potential in patients with acquired hemophilia A: retrospective analyses of plasma samples obtained from nationwide centers across Japan

International journal of hematology, 2022-02, Vol.115 (2), p.163-172

2022

Volltextzugriff (PDF)

1 – 25 von 160

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(154)
Mit Volltextzugriff
(134)

Publikationsform

Artikel
(159)
Berichte
(1)

Sprache

Englisch
(160)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Comparisons of global coagulation potential and bleeding episodes in emicizumab-treated hemophilia A patients and mild hemophilia A patients

Global coagulation function assessed by rotational thromboelastometry predicts coagulation-steady state in individual hemophilia A patients receiving emicizumab prophylaxis

Blood coagulation dynamics during adrenocorticotropic hormone therapy in pediatric patients with infantile spasms

A novel simultaneous clot‐fibrinolysis waveform analysis for assessing fibrin formation and clot lysis in haemorrhagic disorders

Hemostatic rebalance in neonatal intrahepatic cholestasis with citrin deficiency

Hemostatic potential of recombinant von Willebrand factor and standard or pegylated extended half-life recombinant factor VIII on thrombus formation under high shear flow

A modified thrombin generation assay to evaluate the plasma coagulation potential in the presence of emicizumab, the bispecific antibody to factors IXa/X

Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients

Two pediatric cases of severe hemophilia A in which emicizumab prophylaxis failed to prevent traumatic extra-articular hemorrhage

A Novel Assessment of Factor VIII Activity by Template Matching Utilizing Weighted Average Parameters from Comprehensive Clot Waveform Analysis

Potential role of activated factor VIII (FVIIIa) in FVIIa/tissue factor-dependent FXa generation in initiation phase of blood coagulation

High levels of factor VIII activity in patients with acquired hemophilia A in remission are associated with unusually low coagulation potentials

Modified expi293 cell culture system using piggyBac transposon enables efficient production of human FVIII

Characterization of thrombophilia-related plasmas evaluated by anticoagulants-mediated thrombin and plasmin generation assays

Activated partial thromboplastin time-based clot waveform analysis enables measurement of very low levels of factor IX activity in patients with severe hemophilia B

A mild hemophilia B case with postoperative bleeds following thromboprophylaxis

A case of a young boy with hyper-fibrinolysis associated with natural fibrin precipitates suspected to have occurred through a novel coagulation and fibrinolysis mechanism

A microchip flow‐chamber assay screens congenital primary hemostasis disorders

Assessment of Emicizumab-Driven Clot Stability in Hemophilia a Model

The spleen is the major site for the development and expansion of inhibitor producing-cells in hemophilia A mice upon FVIII infusion developing high-titer inhibitor

Evaluation of clinical severity in patients with type 2N von Willebrand disease using microchip-based flow-chamber system

Screening of the protein C pathway abnormality‐related thrombophilia by using thrombomodulin‐mediated tissue factor‐triggered clot waveform analysis

Hemostatic function in hyperfibrinolytic disseminated intravascular coagulation

Mechanism of Tissue Factor (TF) Enhancing Factor (F)VIII Activity on FXa Generation in Initial Phase of Coagulation and Interaction Between TF and FVIII C2 Domain

Comprehensive blood coagulation potential in patients with acquired hemophilia A: retrospective analyses of plasma samples obtained from nationwide centers across Japan

Suchergebnisse filtern